Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-25T04:40:30.070Z Has data issue: false hasContentIssue false
  • English
  • Français

The Modern Treatment of Epilepsy

A Critical Survey, with Special Reference to Sodium Diphenyl Hydantoinate and a Comparison of its Effects with those of Other Anticonvulsants

Published online by Cambridge University Press:  08 February 2018

Donald Blair
Donald Blair*
Affiliation:
Cane Hill Mental Hospital
Get access Rights & Permissions [Opens in a new window]

Extract

Epilepsy is as old as history. To the ancients it was a sacred disease, each convulsion signifying a visitation of its victim by one of the gods. Hippocrates first seriously attributed epilepsy to material causes, but the light of scientific approach which he momentarily kindled was soon extinguished, and for centuries the mysteries of epilepsy remained shrouded in a cloud of mysticism and religious cult, and if treatment was administered at all it usually consisted of incantations and spirit-exorcising rituals. In the modern era of medicine scientific battle has been joined with this disease in common with all others, and since the epileptic, like most other sufferers, is liable to an exacerbation of his disease in times of mental and physical stress, the present human warfare cannot but render more important than ever successes in the therapeutic field against epilepsy.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 86 , Issue 364 , September 1940 , pp. 888 - 927
Copyright
Copyright © Royal College of Psychiatrists, 1940 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliography

Alvarez, W. C. (1938), “New Hope for the Epileptic,” (Edit.), Amer. Journ. Dig. Dis., 5: (August).Google Scholar
Ayer, J. B. (1939), “Dilantin in Epilepsy,” part of a Report on Medical Progress in Neurology, New Eng. Journ. Med., 221, 105 (July 20).CrossRefGoogle Scholar
Black, N. D. (1939), “The Value of Diphenyl Hydantoinate (Dilantin) in Psychoses with Convulsive Disorders,” Psychiatric Quart., 13, 711 (October). Abst. Journ. Amer. Med. Assoc., 113, 2271 (December 16).Google Scholar
Blair, Donald (1939), “The Treatment of Epilepsy by Sodium Diphenyl Hydantoinate (Epanutin),” Post-Graduate Med. Journ., 15, 344 (September).Google Scholar
Idem (1940), “Hemiplegia Complicating Sodium Diphenyl Hydantoinate Therapy in Epilepsy,” Lancet, 1, 269 (February 10).Google Scholar
Idem (1940), ibid., 1, 521.Google Scholar
Idem , Bailey, K. C., and MacGregor, J. S. (1939), “Treatment of Epilepsy with Epanutin,” ibid., 2, 363 (August 12).Google Scholar
Butter, A. J. M. (1940), Brit. Med. Journ., 1, 483.Google Scholar
Cobb, Stanley (1939), “Petit Mal,” Journ. Amer. Med. Assoc., 112, 2626 (June 24).Google Scholar
Cohen, B., Showstack, N., and Myerson, A. (1940), “Synergism of Phenobarbital, Dilantin Sodium and Other Drugs in Treatment of Institutional Epilepsy,” ibid., 114, 484 (February 10).Google Scholar
Coope, R. (1939), “A New Remedy for Epilepsy” (Corres.), Lancet, 1, 180 (January 21).Google Scholar
Idem and Burrows, R. G. R. (1940), ibid., 1, 490.Google Scholar
Council Acceptance Report (1939), Journ. Amer. Med. Assoc., 113, 1734 (November 4).Google Scholar
Davidson, S., and Sutherland, J. (1939), “Results with Epanutin in Mental Hospital Patients,” Brit. Med. Journ., 2, 720 (October 7).Google Scholar
Drake, M. E., Haury, V. G., and Gruber, C. M. (1939), “The Actions of Sodium Diphenyl Hydantoinate on Excised and Intact Uterus,” Arch. Int. Pharm. et Ther., 63, 288 (December).Google Scholar
Fetterman, J. L. (1940), “Dilantin Sodium Therapy in Epilepsy: Report of Study in Progress,” Journ. Amer. Med. Assoc., 114, 396 (February 3).CrossRefGoogle Scholar
Frankel, S. I. (1940), “Dilantin Sodium in the Treatment of Epilepsy,” ibid., 114, 1320 (April 6).Google Scholar
Frost, I. (1939), “Sodium Diphenyl Hydantoinate in Treatment of Epilepsy: Preliminary Observations in Severe Cases,” Journ. Ment. Sci., 85, 976 (September).CrossRefGoogle Scholar
Furtado, D. (1939), “Clinica,” Higiene e Hidrologia, 5, 347.Google Scholar
Gilbert, J. P., (1939) “Epilepsy: Diagnosis and Treatment,” Journ. Tennessee Med. Assoc., 32, 225 (July).Google Scholar
Goldensohn, L. N., Marmor, Judah, and Meyer, B. C. (1940), Journ. Amer. Med. Assoc., 114, 1345.Google Scholar
Goldstein, H. H., and Weinberg, H. J. (1940), Arch. Neurol. Psychiat., 43, 433.Google Scholar
Gruhzit, O. M. (1939), “Sodium Diphenyl Hydantoinate (Dilantin): Pharmacologic and Histopathologic Studies,” Proc. Twenty-Sixth Ann. Meet. Amer. Soc. Exper. Path., Toronto, April 26-29, p. 13.Google Scholar
Haury, V. C., and Drake, M. E. (1940), “Effect of Intravenous Injections of Dilantin Sodium on Respiration, Blood Pressure and the Vagus Nerve,” Journ. Pharm. and Exper. Ther., 68, 36 (January).Google Scholar
Hawke, Williams A. (1939), “Preliminary Observations on Dilantin Therapy of Convulsions,” Soc. Trans., Amer. Journ. Dis. Child., 58, 1143 (November).Google Scholar
Helmholz, H. F. (1939), “Recent Advances in Medicine of Special Significance in Pediatrics,” Journ. Indiana Med. Assoc., 32, 72 (February).Google Scholar
Hodgson, E. R., and Reese, H. H. (1939) “Clinical Experiences with Dilantin in Epilepsies,” Wisconsin Med. Journ., 38, 968 (November 4).Google Scholar
Hyland, H. H., Goodwin, J. E., and Hall, G. E. (1939), “Clinical Applications of Electroencephalography,” Canad. Med. Assoc. Journ., 41, 239 (September).Google Scholar
Kimball, O. P. (1939), “The Treatment of Epilepsy with Sodium Diphenyl Hydantoinate,” Journ. Amer. Med. Assoc., 112, 1244 (April 1).Google Scholar
Idem and Horan, T. N. (1939), “The Use of Dilantin in the Treatment of Epilepsy,” Ann. Inter. Med., 13, 787 (November).Google Scholar
Laws, J. J. (1939), Brit. Med. Journ., 2, 725.Google Scholar
Lennox, W. G. (1938), “A New Remedy for Epilepsy?” (Corres.), Lancet, 2, 1544 (December 31).CrossRefGoogle Scholar
Idem (1940), “The Drug Therapy of Epilepsy,” Journ. Amer. Med. Assoc., 114, 1347 (April 6).Google Scholar
McCartan, W., and Carson, J. (1939), “Use of Sodium Diphenyl Hydantoinate,” Journ. Ment. Sci., 85, 965 (September). Abst., ibid., 113, 1997, November 25, 1939.Google Scholar
McLendon, S. B. (1940), “Epilepsy and Its Management,” Journ. South Carolina Med. Assoc., 36, 40 (February).Google Scholar
Merritt, H. H., and Putnam, T. J. (1938), “A New Series of Anticonvulsant Drugs Tested by Experiments on Animals,” Arch. Neurol. and Psych., 39, 1003 (May).CrossRefGoogle Scholar
Idem (1938), “Sodium Diphenyl Hydantoinate in the Treatment of Convulsive Disorders,” Journ. Amer. Med. Assoc., 111, 1068 (September 17).Google Scholar
Idem (1939), “Sodium Diphenyl Hydantoinate in Treatment of Convulsive Seizures: Toxic Symptoms and Their Prevention,” Arch. Neurol. and Psychiat., 42, 1053 (December).Google Scholar
Pagniez, Ph. (1940), Presse Méd., 25-26, 294.Google Scholar
Philips, David P. (1939), “Epilepsy as a Prison Problem, Its Treatment with Sodium Diphenyl Hydantoinate,” Journ. Michigan State Med. Soc., 38, 317 (April).Google Scholar
Pickles, H. D. (1940), Brit. Med. Journ., 1, 590.Google Scholar
Pratt, C. H. (1939), “Sodium Diphenyl Hydantoinate (Dilantin) and Its Combination with Phenobarbital in Treatment of Epilepsy: Review and Preliminary Report,” Journ. Ment. Sci., 85, 986 (September).CrossRefGoogle Scholar
Putnam, T. J. (1939), “Sodium Diphenyl Hydantoinate as Anticonvulsant,” (Corres.), Journ. Amer. Med. Assoc., 112, 2190 (May 27).Google Scholar
Idem and Merritt, H. H. (1937), “Experimental Determination of the Anticonvulsant Properties of Some Phenyl Derivatives,” Science, 85, 525 (May 28).Google Scholar
Reese, H. H. (1938), “Sodium Diphenyl Hydantoinate in the Treatment of Convulsive Disorders,” Yearbook of Neurol., Psychiat. and Endocrinol., pp. 168–170.Google Scholar
Robinson, Leon J., and Osgood, Rudolf (1940), “Comparative Effects of Phenobarbital and Dilantin Sodium,” Journ. Amer. Med. Assoc., 114, 1334 (April 6).Google Scholar
Schlesinger, B. (1938), “A New Remedy for Epilepsy?” (Corres.), Lancet, 2, 1085 (November 5).Google Scholar
Idem (1939), “A New Remedv for Epilepsy?” (Corres.), ibid., 1, 61 (January 7).Google Scholar
Steel, John P., and Smith, , Seymour, E. (1939), “Epanutin in Epilepsy,” ibid., 2, 367 (August 12).Google Scholar
Weaver, O. M., Harrell, D. L., and Arnold, G. B. (1939), “A Report on the Use of Sodium 5, 5-Diphenyl Hydantoinate in Fourteen Selected Cases of Epilepsy at the Virginia State Colony for Epileptics and Feeble-Minded,” Va. Med. Mo., 66, 522 (September).Google Scholar
Williams, D. (1939), “Epilepsy Treated with Sodium Diphenyl Hydantoinate,” Proc. Roy. Soc. Med., 32, 872 (June).CrossRefGoogle ScholarPubMed
Idem (1939), “Treatment of Epilepsy with Sodium Diphenyl Hydantoinate,” Lancet, 2, 678 (September 23).Google Scholar

Bromides

Barbour, R. F. (1936), Proc. Roy. Soc. Med., 39, 61.Google Scholar
Idem , Pilkington, F., and Sargant, W. (1936), Brit. Med. Journ., 11, 957.Google Scholar
Boshes, Benjamin (1936), Journ. Nerv. and Ment. Dis., 83, 390.Google Scholar
Craven, (1933), Amer. Journ. Psychiatry., 186, 525.Google Scholar
Diethelm, O. (1929), Arch. Neurol. and Psychiat., 21, 664.Google Scholar
Fremont-Smith, , Dailey, M. G., and Sloan, G. H. (1935), ibid., 33, 375.Google Scholar
Paskind, H. A. (1934), Journ. Amer. Med. Assoc., 103, 100.Google Scholar
Pren, P. W., Romand, J., and Brown, W. T. (1936), New Engl. Journ. Med., 214, 57.Google Scholar
Sharpe, (1934), Journ. Amer. Med. Assoc., 102, 1462.Google Scholar
Wagner, C. P., and Bunbury, B. E. (1930), ibid., 95, 1725.Google Scholar

Luminal

Grinker, J. (1920), Journ. Amer. Med. Assoc., 75, 558.Google Scholar
Idem (1922), ibid., 79, 788.Google Scholar
Idem (1929), ibid., 93, 1218.Google Scholar
Golla, F. (1921), Brit. Med. Journ., 2, 320.Google Scholar
Greenwald, (1922), New York Med. Journ., 116, 356.Google Scholar
Handley, R. (1934), Journ. Ment. Sci., 80, 526.Google Scholar
Hanna, J. H. (1927), Practitioner, 2, 262.Google Scholar
Hauptmann, L. (1924), Med. Annual, p. 163.Google Scholar
Jackson, (1927), Journ. Amer. Med. Assoc., 88, 642.Google Scholar
Keeser, and Keeser, (1928), Arch. Exper. Path. in Pharm., 127, 230.Google Scholar
Idem (1935), Journ. Pharm. and Exper. Therap., 53, 137.Google Scholar
Kirk, C. C. (1921), Amer. Journ. Insan., 77, 559.Google Scholar
Lynch, D. O. (1939), Canad. Med. Assoc. Journ., 41, 260 (September).Google Scholar
Patterson, H. A., Damon, L. G. A., and Levi, P. (1926), Journ. Nerv. and Ment. Dis., 63, 446.Google Scholar
Pearcey, J. T., and Weaver, (1927), Amer. Journ. Physiol., 82, 47.Google Scholar
Phillips, (1922), Journ. Amer. Med. Assoc., 78, 1199.Google Scholar
Pratt, C. H. (1928), Canad. Med. Assoc. Journ., 29, 303.Google Scholar
Russell Brown, W. (1929), Lancet, 2, 67.Google Scholar
Tyler Fox, W. (1927), ibid., 2, 589.Google Scholar
Watkins, H. M. (1920), New York Med. Journ., 112, 891.Google Scholar

Prominal

Barber, L. (1936), Brit. Med. Journ. (March 28).Google Scholar
Blun, E. (1932), Deutsch. med. Wochenschr., 18, 696.Google Scholar
Davies, W. J. F. (1937), Board of Control Report, p. 160.Google Scholar
Handley, R. (1934), Journ. Ment. Sci., 80, 526.Google Scholar
Henderson, C. J. (1937), Brit. Med. Journ. (July 10).Google Scholar
Heyde, H. (1932), Klin. Wochenschr., 45, 1874.Google Scholar
Hughes, (1936), Board of Control Report, p. 109.Google Scholar
Jekelius, E. (1934), Wien. med. Wochenschr., 84, 642.Google Scholar
Millman, C. G. (1937), Brit. Med. Journ. (July 10).Google Scholar
Idem (1939), Journ. Ment. Sci., 85, 970.Google Scholar
Page, L. G. (1936), Brit. Med. Journ. (March 14).Google Scholar
Postorff, F. (1932), Ther. Journ. Gegenwart, 8, 351.Google Scholar
Reise, H. (1932), Deutsch. med. Wochenschr., 18, 696.Google Scholar
Sands, D. E. (1937), Journ. Ment. Sci., 83 (November).Google Scholar

Nirvanol

Ashley, H. T. (1930), Arch. Dis. Child., 5, 42.Google Scholar
Curschmann, H. (1918), Therap. Monatsschr., 32, 53.Google Scholar
Gottlieb, A. (1929), Monatsschr. f. Kinderheilk., 43, 433.Google Scholar
Leichentritt, Lansfeld and Silberberg, (1929), Med. Klin., 24, 764.Google Scholar
Lengsfeld, W. (1928), Monatsschr. f. Kinderheilk., 40, 289.Google Scholar
Lesigang, W. (1929), ibid., 43, 469.Google Scholar
Majerus, Karl (1919), Deutsch. f. Nervenkr., 63, 312.Google Scholar
Poynton, F. J., and Schlesinger, B. (1929), Lancet, 2, 267.Google Scholar
de Rudders, B. (1926), Zeitschr. f. Kinderheilk., 42, 361.Google Scholar
Wernecke, (1926), Deutsch. med. Wochenschr., 42, 1193.Google Scholar
Whitaker, W. M. (1930), Arch. Dis. Child., 5, 44.Google Scholar

General

Alcock, N. S. (1938), Mental Welfare, 19, 7.Google Scholar
Cushny, (1936), Text-book of Pharmacology and Therapeutics. London: Churchill.Google Scholar
Gibbs, F. A., Gibbs, E. L., and Lennox, W. G. (1937), “Epilepsy a Paroxysmal Cerebral Dysrhythmia,” Brain, 60, 377.Google Scholar
Golla, F., Graham, S., and Grey Walter, VV. (1937), Journ. Ment. Sci., 83 (March).Google Scholar
Krasnogorski, (1935), quoted by Putnam, and Merritt, (1937) (see Epanutin bibliography).Google Scholar
Lennox, W. G. (1933), New Eng. Med. Journ., 209, 386.Google Scholar
Idem (1940), Journ. Amer. Med. Assoc., 114, 1346 (April 6).Google Scholar
Idem , Gibbs, E. L., and Gibbs, F. A. (1939), ibid., 113, 1002.Google Scholar
Paskind, H. A. (1932), Arch. Neur. Psychiat., 28, 370.Google Scholar
Idem and Brown, Meyer (1936), ibid., 36, 1937.Google Scholar
Sollman, T. (1936), Manual Pharm. Philadelphia: Saunders. 1936.Google Scholar
Spiegel, (1937), quoted by Putnam, and Merritt, .Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.